November 18, 2009 (Orlando, Florida) — There was no difference in clinical outcomes between 2.5 mg, 5 mg, and 20 mg daily of carvedilol in Japanese heart-failure patients in the Japanese Chronic Heart ...
Please provide your email address to receive an email when new articles are posted on . A low-dose regimen of the blood pressure medication carvedilol demonstrated safety and efficacy in improving ...
The use of low-dose carvedilol did not significantly improve certain cardiac measures of heart failure risk in long-term survivors of childhood cancer exposed to anthracycline compared with placebo, ...
Aims Various beta-blockers with distinct pharmacological profiles are approved in heart failure, yet they remain underused and underdosed. Although potentially of major public health importance, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results